Home > Healthcare > Medical Devices > Medical Supplies > Hypodermic Syringes & Needles Market

Hypodermic Syringes & Needles Market Size

Report ID: GMI5556
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Hypodermic Syringes & Needles Market Size

Hypodermic Syringes & Needles Market size exceeded a valuation of USD 6.5 billion in 2022. The industry is anticipated to grow at a 3% CAGR from 2023 to 2032, driven by the increasing burden of chronic conditions and infectious diseases.

Latin America Hypodermic Syringes & Needles Market

To get key market trends

Download Free Sample

The demand for hypodermic needles & syringes is primarily fueled by mounting surgeries and procedural volumes across the world. The rapid growth in the elderly population is boosting the need for medical surgeries to enhance their quality of life. Furthermore, ongoing advancements are also enhancing the outlook for minimally invasive surgical procedures that employ safe, sterile, and less-invasive equipment, such as hypodermic syringes & needles in treating multiple ailments, which is likely to complement the business share.

Hypodermic Syringes & Needles Market Report Attributes
Report Attribute	Details
Base Year:	2022
Hypodermic Syringes & Needles Market Size in 2022:	USD 6.8 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	3%
2032 Value Projection:	USD 9.3 Billion
Historical Data for:	2018 to 2022
No. of Pages:	200
Tables, Charts & Figures:	359
Segments covered:	Type, Usability, Application, End-use, and Region
Growth Drivers:	Rising incidence of chronic disorders Increase in the number of surgeries Increasing demand for syringes for mass vaccination Surged adoption of syringes & needles for blood collection
Pitfalls & Challenges:	Risk of needlestick injuries & infection

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for hypodermic syringes & needles was valued at more than USD 6.5 billion in 2022 and is primed to progress at 3% CAGR between 2023 and 2032 propelled by the increasing burden of chronic conditions and infectious diseases.

The needles segment accounted for nearly 53% market share in 2022 as a result of the emergence of vaccination campaigns and their surging use in medical procedure that incorporates hypodermic needles.

Hospitals end-use segment is anticipated to garner a value of more than USD 5 billion by the end of 2032 owing to ongoing advancements in medical technology, increased awareness regarding infection control, and the need for accurate and precise medication administration.

North America hypodermic syringes & needles growth is slated to surpass a valuation of USD 2.5 billion by 2032 on account of the booming prevalence of cardiovascular diseases, mounting cases of diabetes, and frequent novel product launches, especially in the U.S.